- Brand names:
- Pharmaceutical Company:
- Condition/Indication:
- Meeting Date: March 2013
- Public Summary Document (PSD) March 2013 PBAC Meeting - PDF
Alglucosidase alfa alfa-rch – March 2013
Alglucosidase alfa-rch, powder for IV infusion, 50 mg, Myozyme®
Last updated
8 November 2023